Firebrick Pharma
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAFirebrick Pharma is an Australian pharmaceutical developer, founded in 2012 by Dr Peter Molloy and Dr Stephen Goodall, with the mission to develop a nasal spray that killed all the germs (viruses or bacteria) responsible for respiratory infections such as the common cold.
Its first product, Nasodine® Nasal Spray, is in the final stages of development. Nasodine Nasal Spray contains the broad-spectrum antimicrobial agent, povidone-iodine. If approved, Nasodine will be the world's first nasal spray medicine that targets the cause of colds.
Firebrick Pharma listed on the ASX on 28 January 2022.
Contact Details
Level 10, 440 Collins Street, MELBOURNE VIC 3000
1300 301 874
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1165th |  | Firebrick Pharma | $23k |
| 1285th | | Australia United Mining | -$408k |
| 1286th | | ECP Emerging Growth | -$839k |
| 1288th | | American Rare Earths | -$1.1m |
| 1289th | | CD Private Equity Fund II | -$1.2m |
1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 31/10/23
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 261st | ECP Emerging Growth | 28% | 8% |
| 264th | CD Private Equity Fund II | 28% | 11% |
| 1101st | Australia United Mining | -25% | 0% |
| 1250th | American Rare Earths | -33% | 22% |
| 1919th | Firebrick Pharma | -85% |
1838 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEWS: Tagged in Kula Gold: Fast cars, fast share price | 17 Nov 2023 |
| NEW ROLE: Linda Friedland, Medical Consultant | 18 Oct 2023 |
| ECM DEAL: New deal has been added | 11 Jul 2023 |
| ECM DEAL: New deal has been added | 22 Jun 2023 |
| NEW ROLE: Kavi Bekarma, Chief Financial Officer | 14 Nov 2022 |
| NEW ROLE: Kyla Garic, Chief Financial Officer | 14 Nov 2022 |
| ECM DEAL: New deal has been added | 28 Jul 2022 |
| NEWS: Tagged in Board Moves May 25, 2022 | 25 May 2022 |
| NEW ROLE: Richard Treagus, Non-Executive Director | 25 May 2022 |
